1394010-75-3Relevant academic research and scientific papers
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl- thiophene-carboxamidine inhibitors of the complement component C1s
Subasinghe, Nalin L.,Khalil, Ehab,Travins, Jeremy M.,Ali, Farah,Ballentine, Shelley K.,Hufnagel, Heather R.,Pan, Wenxi,Leonard, Kristi,Bone, Roger F.,Soll, Richard M.,Crysler, Carl S.,Ninan, Nisha,Kirkpatrick, Jennifer,Kolpak, Michael X.,Diloreto, Karen A.,Eisennagel, Stephen H.,Huebert, Norman D.,Molloy, Christopher J.,Tomczuk, Bruce E.,Gaul, Michael D.
, p. 5303 - 5307 (2012/09/07)
Complement C1s protease inhibitors have potential utility in the treatment of diseases associated with activation of the classical complement pathway such as humorally mediated graft rejection, ischemia-reperfusion injury (IRI), vascular leak syndrome, an
